Archive for: October 2008

HealthDay - THURSDAY, Oct. 30 (HealthDay News) -- A new study shows that men who take cholesterol-lowering drugs called statins have lower blood levels of prostate-specific antigen (PSA), a biomarker for prostate cancer risk.

American Cancer Society - The National Cancer Institute has stopped a major clinical trial studying whether vitamin E and selenium can prevent prostate cancer because early analysis suggests the supplements don't work. What's more, there is some evidence that they may actually be harmful.

Reuters - Cholesterol-lowering drugs called statins modestly reduce levels of a protein in a man's blood that doctors often use to screen for prostate cancer, researchers said on Tuesday.

AP - The government is stopping part of a major study of whether vitamin E and selenium prevent prostate cancer — because the supplements aren't working and there's a hint of risk.

Reuters - Selenium and vitamin E supplements do not prevent prostate cancer and may in fact be a little bit dangerous, U.S. researchers reported on Monday.

Reuters - Exposure to bisphenol A (BPA) -- a man-made chemical found in a number of plastic products, including drinking bottles and the lining of food cans -- may reduce the effectiveness of chemotherapy treatments, scientists report in the latest issue of Environmental Health Perspectives.

Reuters - A mutated gene previously linked to breast cancer has been found in 70 percent of prostate tumors as well, U.S. researchers reported on Friday.

HealthDay - WEDNESDAY, Oct. 22 (HealthDay News) -- Using just a single adult stem cell, scientists say they have grown entire prostates in mice.

HealthDay - WEDNESDAY, Oct. 22 (HealthDay News) -- Using just a single adult stem cell, scientists say they have grown entire prostates in mice.

AFP - Molecular biologists reported Wednesday that they had grown prostates in mice from single cells, marking an important step forward in the quest to grow transplant tissue in the lab.